98%
921
2 minutes
20
Introduction: Fragility fractures are the major consequence of osteoporosis. Thus, fracture risk assessment is an essential part of the diagnostic process in osteoporosis.
Objectives: The aim of the study was to develop an algorithm for fracture risk prediction.
Patients And Methods: Bone status was evaluated in a population‑basedcohort of postmenopausal women at a mean (SD) age of 66.4 (7.8) years. Subsequently, all participants were contacted by phone once a year (for 10 consecutive years) to update their history of fractures. At the end of the 10‑year follow‑up, the number of the study participants was 640, of whom 129 had a history of 190 osteoporotic fractures recorded during the study period. Statistical analysis included multistep data preprocessing, feature selection, identification of fracture risk factors, and design of the final model. Logistic regression models were fitted and used for the evaluation of variables from determined feature sets, including global fit measures, as well as individual parameters, such as the Wald statistic and P value, odds ratio, and 95% CI.
Results: The 10‑year risk for any fracture depended on the age of the patient, the number of recorded fractures after the age of 40 years, femoral neck bone mass, and the occurrence of falls during the previous year. The achieved equation was incorporated into an algorithm, available at the www.fracture‑risk.pl webpage.
Conclusion: A fracture prediction algorithm was developed in a longitudinal study to enable calculation of the 10‑year fracture risk. Identification of patients at a high risk of fracture should be followed by implementation of appropriate treatment strategy to reduce the number of future fractures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.20452/pamw.16395 | DOI Listing |
Eur J Case Rep Intern Med
August 2025
General medicine department, Universidad de Cartagena, Cartagena, Colombia.
Background: Romosozumab is a sclerostin-inhibiting monoclonal antibody that is effective and safe for anabolic treatment in patients with osteoporosis. Its main adverse effects are local; the severity of these injection-site reactions in clinical trials was generally mild.
Case Report: We present a case of a 71-year-old Colombian woman with osteoporosis at very high risk of fractures with no relevant history of drug allergies.
Background: Anticonvulsants are widely used in treating patients with mental and neurological disorders. Their long-term use increases the risk of a decrease in bone mineral density (BMD) and low-energy fractures. Despite the growing number of studies of drug-induced osteoporosis, the effect of anticonvulsants on bone microarchitecture remains poorly studied.
View Article and Find Full Text PDFJB JS Open Access
September 2025
University of Glasgow, Glasgow, United Kingdom.
Background: Open fractures are common and severe injuries that are associated with poor functional outcomes and quality of life, and high societal costs. Several classifications systems have been developed to characterize these injuries, predict prognosis and plan treatment. We aimed to assess the agreement between open fracture classification and patient-reported function, fracture-related infection, and amputation.
View Article and Find Full Text PDFJ Rehabil Med Clin Commun
September 2025
Department of Medicine, Division of Endocrinology, Western University, London, Canada.
Objective: People who have experienced stroke are at a high risk for falls, fractures, and osteoporosis. Bone health post-stroke is often overlooked. The goal of this study was to understand current practice perspectives and barriers to bone health care post-stroke among physiatrists.
View Article and Find Full Text PDFClin Interv Aging
September 2025
Department for Orthopedics, Traumatology and Plastic Surgery, University Hospital, Leipzig, Germany.
Study Design: Systematic review.
Purpose: As the number of elderly increases, age-related changes of body composition like osteoporosis and sarcopenic muscle changes contribute to higher morbidity, less quality of life and higher health care costs. Data on the effect of muscle atrophy on osteoporotic vertebral fractures is limited.